How to save money on medication
The 5 pillars of longevity: Movement, nutrition, sleep, stress reduction, and social connection
Newly approved pill cuts LDL cholesterol levels by more than half
C-reactive protein: Should healthy people be tested for it?
Loneliness linked to cognitive decline and early death
PRP injection for knee osteoarthritis: Does it work?
Strength training over decades linked to longer life
Senator's death calls attention to aortic dissection
Taking breaks from sitting to move around may lower cancer risk
GLP-1 weight-loss drugs may lower the need for knee replacement
Guru P. Sonpavde, MD
Contributor
Guru P. Sonpavde, MD is the director of the bladder cancer program at Dana-Farber Cancer Institute and is on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus is on clinical trials to develop new drugs and combinations to treat urologic cancers, particularly bladder cancer. He also has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. He is a member of the Genitourinary Committee of Southwest Oncology Group and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee.
Posts by Guru P. Sonpavde, MD
Guru P. Sonpavde, MD
Cancer treatment: Is a clinical trial right for you?
Healthy aging and longevity
Immunotherapy: What you need to know
How to save money on medication
The 5 pillars of longevity: Movement, nutrition, sleep, stress reduction, and social connection
Newly approved pill cuts LDL cholesterol levels by more than half
C-reactive protein: Should healthy people be tested for it?
Loneliness linked to cognitive decline and early death
PRP injection for knee osteoarthritis: Does it work?
Strength training over decades linked to longer life
Senator's death calls attention to aortic dissection
Taking breaks from sitting to move around may lower cancer risk
GLP-1 weight-loss drugs may lower the need for knee replacement
